enVVeno Medical/$NVNO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About enVVeno Medical
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Ticker
$NVNO
Sector
Primary listing
Employees
33
Headquarters
Website
enVVeno Medical Metrics
BasicAdvanced
$7.7M
-
-$33.06
1.09
-
Price and volume
Market cap
$7.7M
Beta
1.09
52-week high
$12.85
52-week low
$8.67
Average daily volume
14K
Financial strength
Current ratio
13.584
Quick ratio
13.295
Long term debt to equity
1.143
Total debt to equity
2.58
Profitability
EBITDA (TTM)
-20.763
Management effectiveness
Return on assets (TTM)
-35.06%
Return on equity (TTM)
-56.21%
Valuation
Price to book
0.28
Price to tangible book (TTM)
0.28
Price to free cash flow (TTM)
-0.443
Free cash flow yield (TTM)
-225.98%
Free cash flow per share (TTM)
-26.44
Growth
Earnings per share change (TTM)
-25.76%
3-year earnings per share growth (CAGR)
-28.69%
enVVeno Medical News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for enVVeno Medical stock?
enVVeno Medical (NVNO) has a market cap of $7.7M as of April 19, 2026.
What is the P/E ratio for enVVeno Medical stock?
The price to earnings (P/E) ratio for enVVeno Medical (NVNO) stock is 0 as of April 19, 2026.
Does enVVeno Medical stock pay dividends?
No, enVVeno Medical (NVNO) stock does not pay dividends to its shareholders as of April 19, 2026.
When is the next enVVeno Medical dividend payment date?
enVVeno Medical (NVNO) stock does not pay dividends to its shareholders.
What is the beta indicator for enVVeno Medical?
enVVeno Medical (NVNO) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.